Back to Results
First PageMeta Content
ISTA Pharmaceuticals / Ophthalmology / Non-steroidal anti-inflammatory drugs / Piperazines / Cyclopropanes / Medicine / Dermatologic and Ophthalmic Drugs Advisory Committee / Food and Drug Administration


Anti-Inflammatory Drugs for Post-operative Indications Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) February 27, 2012 Renata Albrecht, MD
Add to Reading List

Open Document

File Size: 261,62 KB

Share Result on Facebook

Company

ISTA Pharmaceuticals / /

IndustryTerm

topical ophthalmic anti-inflammatory drugs / anti-inflammatory ophthalmic products / /

MedicalCondition

infection / further address infection / /

MedicalTreatment

surgery / /

Organization

office of Antimicrobial Products / FDA / Advisory Committee / Division of Transplant / Division of Transplant and Ophthalmology Products / Ophthalmic Drugs Advisory Committee / Transplant and Ophthalmology Products Advisory Committee / office of New Drugs / Post-operative Indications Dermatologic and Ophthalmic Drugs Advisory Committee / /

Person

Renata Albrecht / Arch Ophthalmol / Wiley A. Chambers / /

Position

Should physician / Deputy Director / Director / /

URL

http /

SocialTag